UNITED PHARMA TECHNOLOGIES, INC.
US H-1B Labor Condition Application activity for UNITED PHARMA TECHNOLOGIES, INC.. Filed 351 disclosures between FY2016 and FY2026 from worksites with a NJ headquarters indicator.
H-1B outcome breakdown
Share of UNITED PHARMA TECHNOLOGIES, INC.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 90.9% |
| Cert-withdrawn | 3.7% |
| Withdrawn | 5.4% |
Top occupations sponsored
SOC codes filed most by UNITED PHARMA TECHNOLOGIES, INC. across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 17-2112 | Industrial Engineers | 225 |
| 2 | 13-1041 | Compliance Officers | 33 |
| 3 | 15-2051 | Data Scientists | 15 |
| 4 | 15-1253 | Software Quality Assurance Analysts and Testers | 14 |
| 5 | 15-1252 | Software Developers | 10 |
| 6 | 19-1022 | Microbiologists | 5 |
| 7 | 11-9121 | Natural Sciences Managers | 5 |
| 8 | 15-1299 | Computer Occupations, All Other | 3 |
| 9 | 15-1211 | Computer Systems Analysts | 3 |
| 10 | 17-2041 | Chemical Engineers | 2 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2016 | 17 |
| FY2017 | 43 |
| FY2018 | 47 |
| FY2019 | 46 |
| FY2020 | 1 |
| FY2021 | 5 |
| FY2022 | 3 |
| FY2023 | 26 |
| FY2024 | 81 |
| FY2025 | 48 |
| FY2026 | 34 |
| Period | Value |
|---|---|
| FY2016 | 17 |
| FY2017 | 43 |
| FY2018 | 47 |
| FY2019 | 46 |
| FY2020 | 1 |
| FY2021 | 5 |
| FY2022 | 3 |
| FY2023 | 26 |
| FY2024 | 81 |
| FY2025 | 48 |
| FY2026 | 34 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.